IN THE NEWS: Dr. Winer's Thoughts on SGO 2022


Ira Winer, M.D., Ph.D., FACOG, member of the Gynecologic Oncology Multidisciplinary Team at Karmanos, recently presented Clinical Outcomes of Ovarian Cancer Patients Treated with the Novel Engineered Cytokine Nemvaleukin Alfa in Combination with the PD-1 Inhibitor Pembrolizumab: Recent Data from ARTISTRY-1 at The Society of Gynecologic Oncology (SGO) 2022 Annual Meeting on Women’s Cancer. Following the conference, Dr. Winer speaks to the CancerNetwork about the presentations he found most interesting this year and how the research presented at this conference shows a positive direction toward finding treatments that better target gynecologic cancers. Listen to his interview with the CancerNetwork here.

For more information about Karmanos’ Gynecologic Oncology Multidisciplinary Team, click here.